DeepMed Research

JNJ-18054478

Generic Name: JNJ-18054478

Clinical Trials

Effectiveness and Safety Study for JNJ-18054478 in Asthma Patients.

Phase 2

Terminated

Conditions: Asthma

Interventions: Drug: JNJ-18054478
Drug: sham comparator

First Posted Date: 2007-09-17

Last Posted Date: 2014-06-18

Lead Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Target Recruit Count: 26

Registration Number: NCT00530166

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy